We have analyzed the functions encoded by the bgl operon in-Escherichia coli K-12. Based on the ability of cloned regions of the operon to complement a series of Bgl-point mutations, we show that the three bgl structural genes, bglC, bglS, and bglB, are located downstream of the regulatory locus bglR in the order indicated. Using a bgl-lacZ transcriptional fusion, we show that bglC and bglS are involved in regulating operon expression. The presence of the bglC gene in trans is absolutely required for the expression of the fusion, which is constitutive when only the bglC gene is present. When the bglC and the bglS genes are both present in the ceil, expression of the fusion requires a f-glucoside inducer. From these observations, we conclude that (i) the bglC gene encodes a positive regulatory of bgl operon expression and (ii) the bglS gene encodes a negative regulator of operon expression, causing the requirement for a 0-glucoside inducer. These conclusions are supported by our observations that (i) a majority of bglC mutants exhibits a Bgl-phenotype, whereas rare trans-dominant mutations in bglC result in constitutive expression of the bgl operon and the fusion, and (ii) mutations in the bgLS gene lead to constitutive expression of the fusion. Based on several lines of evidence presentedi, we propose that the bglS gene product has an additional role as a component of the j8-glucoside transport system.
presentedi, we propose that the bglS gene product has an additional role as a component of the j8-glucoside transport system.
The bgl operon in Escherichia coli K-12 specifies the enzymes involved in the catabolism of aromatic 3-glucosides such as arbutin and salicin. The operon is cryptic and uninducible in wild-type strains, and therefore wild-type cells are unable to utilize salicin or arbutin as a carbon source. Several classes of mutations have been shown to activate the cryptic operon. The major class of activating mutations is effective in cis and has been characterized as insertions of IS] or IS5 or point mutations that map within the regulatory locus bglR (9) . The insertion sequences and point mutations have been shown to enhance transcription from the unique bgl promoter, present in the bglR region, which is active at a low level in wild-type cells (10) . Transcriptional activation, however, does not result in constitutive expression of the operon. After activation, induction of the operon requires the presence of a P-glucoside sugar. Expression of the operon is also subject to catabolite repression.
In addition to the bglR site, three structural genes of the bgl operon were reported earlier (7) . The bglB gene was shown to encode the enzyme phospho-i-glucosidase B, which hydrolyzes phosphosalicin. The structural gene encoding the ,B-glucoside transport system I, the bgl-specific component of the phosphoenol pyruvate-dependent phosphotransferase system (2) , was identified by measuring phospho-p-glucosidase B activity in cell extracts from Bglmutants. A trans-dominant mutation, which led to constitutive bgl expression, suggested the presence of a third bgl gene. Based on the unique phenotype of the constitutive mutation, it was postulated that expression of phospho-3-glucosidase B and the ,B-glucoside transport system is under positive control. Initial mapping of the bgl genes suggested that the genes encoding the hydrolytic and transport functions are located on either side of the bglR site, forming divergent transcriptional units.
An unlinked locus termed bglA, which specifies a second phospho-p-glucosidase, has been identified (8) . This enzyme, termed phospho-,B-glucosidase A, preferentially cleaves phosphoarbutin and is produced constitutively by wild-type cells. However, wild-type cells are unable to utilize arbutin due to lack of expression of the P-glucoside transport system I of the bgl operon. Therefore, arbutin utilization also requires an activated bgl operon for uptake and phosphorylation of the substrate. The results presented in this paper confirm the presence of three structural genes in the bgl operon. We show that the three genes bglC, bglS, and bglB are contained within a 5.7-kilobase (kb) region downstream from the transcription start site in bglR characterized previously (10) . This operon structure, indicated by our observations, differs from the structure proposed earlier (7) . Based on studies with a bgl-lacZ transcriptional fusion, we show that the first gene in the bgl operon, bglC, encodes a positive regulator of bgl operon expression. We also show that the second gene, bglS, encodes a negative regulator of the bgl operon. However, loss of bglS gene function simultaneously results in a Bgl-phenotype, suggesting that the bglS gene product also has a direct role in P-glucoside utilization. We propose that the bglS gene product, in addition to being a negative regulatory of bgl operon expression, is the bgl-specific component of the phosphoenolpyruvate-dependent phosphotransferase system. Specific roles of the bglC and bglS genes in the regulation of the operon are considered.
MATERIALS AND METHODS
Strains. The E. coli K-12 strains used in this study are listed in Table 1 . AE10 is a spontaneous Bgl+ derivative of As MA46 and X bglR7 bglC' lacZ+ lacY+ ((bgl-lac)
MA110
As AE10 tna and A(bgl-pho) srl::TnJO recA56
MA152
As MA110 and X bglR7 bglC' lacZ+ lacYr (F(bgl-lac)
MA200
As MA10 and X bgiR7 bglC' lacZ+ lacsA (D(bgl-lac) (bgl2 ) MA200-1 As MA200 and bglS201 MA200-2
As MA200 and bglS202 MA200-3
As MA200 and bglS203 MA200-4
As MA200 and bglS204 MA200-33
As MA200 and bglC33 (Bglc)
MA221
As AE325 and tna+ recA56 lac bgiC21 MA222 As AE325 and tna+ recA56 lac bglC22 MA223
As AE325 and tna+ recA56 lac bglB23(Ts)
MA225
As AE325 and tna+ recA56 lac bglB25
MA226
As AE325 and tna+ recA56 lac bglB26(Ts) the laboratory strain RV. The activating mutation present in AE10 was characterized as an IS] insertion in bgiR. AE304, a derivative of strain AE10, was used as the parent strain for transducing one class of bgl mutations from WP72 after localized mutagenesis (described below). The mutations were transduced by using a TnJO insertion in the tnaA gene. The bgl operon can be cotransduced with tna at about 80% efficiency. Strains MA221 through 234 were derivatives of strain AE325 carrying a second set of bgl mutations transduced from WP72 after mutagenesis as in the previous case. The recA56 allele was introduced by using a TnJO insertion in srl after transducing the tna::TnJO mutation to tna+.
The strain JF201, which carries a deletion of the chromosomal bgl operon and the adjacent phoUT genes, was described previously (10 (15) .
The plasmids pAR16 and pMN33, carrying the bglC4 and bglC33 alleles, respectively, were derived by transferring the bglC mutations from the chromosomes of the parent strains to a bgl plasmid as described earlier (10) . Hybrid plasmids containing wild-type and mutant sequences, used in the mapping of the two bglC alleles, were constructed as shown in Fig. 4 .
Media. Minimal and enriched media for routine use were prepared from standard recipies (6) . Media used for growing strains carrying pBR322-derived plasmids contained 100 ,ug of ampicillin per ml. MacConkey arbutin and salicin media were prepared as described previously (11) .
Localized mutagenesis of the bgl operon. The Bgl-mutants employed in the genetic analysis of the bgl operon were generated by localized mutagenesis of the bgl operon region. The Bgl+ parent strain WP72, which carries a TnlO transposon in the tnaA gene (80% cotransducible with bgo, was mutagenized with nitrosoguanidine (6) . Bacteriophage P1 was grown on the mutagenized strain, and the resulting lysate was used to transform a Bgl+ strain to tetracycline resistance. Tetr transductants were screened for the simultaneous acquisition of a bgl mutation. In this way we were able to enrich for mutations in the bgl operon. Eighteen Bglmutants isolated from 664 Tetr transductants were used for further analysis. Mutations in the bglB gene were identified by their characteristic Arb+ Sal-phenotype. Temperaturesensitive and amber mutations were recognized by the suppression of the Bgl-phenotype under permissive conditions.
Molecular cloning. All manipulations with recombinant DNA were carried out by standard procedures (5). Restriction enzymes and other enzymes used in recombinant DNA experiments were purchased commercially and were used according to the specifications of the manufacturers.
Construction of a bgl-laeZ transcriptional fusion. The bgllacZ transcriptional fusion used in these studies was constructed in vitro by fusing sequences containing an IS5-activated bgl promoter and a portion of the bglC gene to lacZ. This construction strategy is outlined in Fig. 1 . A 12-kb HindIII-BamHI fragment containing the bgl sequences and the pBR322 vector, derived from plasmid pAR7, was isolated and ligated with an 8-kb HindIII-BamHI fragment containing the lacZYA genes derived from the plasmid pMB041 (3). The ligated DNA was used to transform the Bgl+ strain MA10. Ampr transformants were screened on minimal succinate medium containing X-gal (5-bromo-4-chloro-3-indolyl-f-D-galactopyranoside), the chromophoric substrate for P-galactosidase, and 10 mM 3-methyl glucoside as inducer. The presence of the correct fusion was verified by restriction analysis of plasmid DNA isolated from transformants that gave rise to blue colonies. The bgl-lacZ fusion was transferred from the plasmid pMN200 to the X vector NF1955 (11) by ligating EcoRI digests of the plasmid and X NF1955 DNA. The ligated DNA was packaged in vitro with X packaging extracts (11) . Phages carrying the bgl-lacZ fusion gave pale blue plaques on X-gal plates with a lawn of an Su' host deleted for the chromosomal lac operon. The X cI857 and the X SamlOO mutations, present in the original isolates, were replaced with the respective wild-type alleles by crossing the phage with wild-type X phage. The recombinant phages were recognized by their ability to form turbid blue plaques on X-gal plates at 37°C with an Su-host.
Measurements of 13-galactosidase activity. Assays forgalactosidase activity were carried out as described previously (6) . Cells were grown in minimal medium containing 0.4% succinate as the carbon source. Average values of units of activity were computed based on at least four independent measurements in each case.
Screening for constitutive expression of the bgl operon. Constitutive expression of the bgl operon was detected by using para-nitrophenyl-p-glucoside as a substrate (7). U, pBR322 sequences. Phenotypes of the resulting plasmids were tested in strain JF201 (Abgl-pho-201).
the cleavage of the phosphorylated substrate, which liberated the chromophore p-nitrophenol. RESULTS Location of the bgl genes relative to the bglR site. The bglR region contains the transcription start site and the target sites for insertion sequences and point mutations that activate the bgl operon (10) . Earlier genetic analysis with three-factor cotransductional crosses had suggested that the bglR site is located between two bgl structural genes (7). Based on this result, it was proposed that the bgl structural genes are transcribed bidirectionally from bglR.
We determined the location of the bgl structural genes with respect to the bglR site by subcloning DNA located on either side of the bglR site. EcoRI restriction fragments from the Bgl+ plasmid pAR7, which contains an EcoRI site in the activating IS5 element in bglR, were subcloned in pBR322 and analyzed for bgl function (Fig. 2) . One of the resulting plasmids, pAR8, which contained 1.1 kb of the activating IS5 insertion and 5.7 kb of DNA downstream of the bgl promoter in bglR (10), conferred a Sal' Arb+ phenotype on strains deleted for the chromosomal bgl operon. Expression of the bgl operon in pAR8 was inducible by P-glucosides and required cyclic AMP binding protein and cyclic AMP. The 6.9-kb EcoRI restriction fragment conferred an identical phenotype when present in single copy in the chromosome as part of a A prophage. These results indicate that the bgl structural genes are contained within the 5.7-kb region downstream of the bglR site.
Mapping of bgl mutations. To analyze the functions encoded by the bgl operon, we isolated a series of Bglmutants by using localized mutagenesis as described in Materials and Methods. The locations of 18 bgl mutations were determined by complementation analysis with a series of plasmids containing different portions of the bgl operon (Fig. 3) . Plasmids pAR10, pAR18, and pMN25 were derived from Bgl+ plasmids and contain an activated bgl promoter. Plasmids plH, pMN5, and p6J are deleted for the bglR site but still express the cloned bgl genes, presumably from a promoter within the tet gene of the pBR322 vector (15) . Transformants of the various Bgl-mutants carrying these deletion plasmids were screened on MacConkey salicin plates for complementation. Positive complementation was indicated by the formation of bright red colonies. The results of these studies (Table 2) indicate that the bgl mutations fall into three groups based on complementation by specific bgl plasmids. The properties of each group of Bgl-mutants are described below.
The bgl mutations in strains AE304-7, -9, and -10 and MA221, 222, and 233 were complemented strongly by plasmid pMN25 (complementation of AE304-10 and MA222 was weaker compared with the others). Plasmid pAR10, which carries DNA up to the first HindIII site in the operon, gave only partial complementation of these mutants as indicated by the formation of pale pink colonies on MacConkey salicin plates. These results indicate that a gene, which we have designated bglC, extends beyond the first HindIII site but does not extend beyond the second HpaI site downstream of the bgl promoter (Fig. 3) . The partial complementation observed with pAR10 is likely to be due to a low level of activity of the truncated bglC gene product, when expressed from a multicopy plasmid.
The bgl mutations in strains AE304-1, -2, and -4 and MA231 were complemented strongly by plasmid plH, but not by p6J. Therefore, these mutations define a gene, which we structural gene encoding the enzyme phospho-p-glucosidase B, which preferentially cleaves phosphosalicin (7). Strains with bglB mutations can utilize arbutin, by using the unlinked locus bglA (8) , and the P-glucoside transport system I, specified by the bgl operon (7) . Plasmid pAR18, which carries bgl DNA up to the second HindIII site in the operon (Fig. 3) , confers an Arb+ Sal-phenotype to cells deleted for the chromosomal bgl operon, indicating that this HindIII site lies within the bglB gene.
Plasmid pMN5, which carries DNA from the first HindIlI site to the ClaI site (Fig. 3) , complemented the bglS mutations described above, resulting in an Arb+ phenotype. However, these transformants had a Sal-phenotype, suggesting that the bglS mutations tested were polar on the bglB gene. The same results were obtained when these bglS mutants contained pAR18 ( Table 2 ). The complementation to Arb+ by pMN5 indicates that the bglS gene is contained within the 2.3-kb HindIII-ClaI fragment.
The analyses described above indicate the presence of three bgl structural genes located downstream of bglR in the order bglC bglS bglB.
Identification of the regulatory genes. Analysis of bgl operon regulation was carried out by using a bgl-lacZ transcriptional fusion constructed as described in Materials and Methods. The fusion, present in single copy on a A prophage, contained the bgl promoter including the activating IS5 mutation and a portion of the bglC gene. Regulation of expression of the fusion was studied by measuring Igalactosidase activity in strains with different bgl genotypes (Table 3 ). In strain MA152, which is deleted for the chromosomal bgl operon, little expression from the bgl-lacZ fusion was detected by colony color on MacConkey lactose plates or by P-galactosidase assays. However, constitutive expression of the fusion was observed when plasmid pMN25, carrying the complete bglC gene, was present in the cell. Plasmid pMN5, which expresses only the bglS gene, had no effect on the expression of the fusion. In the presence of plasmid pAR18 (bglC+ bglS+) or plasmid pSAL6 (bglC+ bglS+ bglB+), the expression of the fusion was inducible by p-glucosides. stitutive expression of the bgl-lacZ fusion. Strain MA200, a and simultaneous loss of bgl expression are linked to the Bgl+ strain lysogenic for the X phage carrying the transcripchromosomal bgl operon. tional fusion, was used to isolate mutants that express the Mutations in MA200-1 through -4 were mapped more fusion constitutively. Spontaneous Lac+ mutants were isoprecisely by complementation analysis with the deletion lated by their ability to grow on minimal lactose medium in plasmids described above (Table 4) . Plasmids pMN25 and the absence of a ,B-glucoside inducer. The major class of p6J, expressing the bglC and bglB genes, respectively, had spontaneous Lac+ derivatives (83 of 84) had a Lacc Bglno effect on the strains. However, transformants of the phenotype. Four representative strains from this class, mutant strains carrying plasmid plH, which expresses the MA200-1 through -4, were chosen for detailed analysis. A bglS and bglB genes, showed an Arb+ Sal+ phenotype. The single Lacc isolate, MA200-33, showed constitutive exprespresence of an intact bglS gene also resulted in inducible sion of the bgl operon (see below).
expression of the bgl-lacZ fusion. These results indicate that The observation that the Lacc mutations present in strains the mutations in strains MA200-1 through -4, which lead to MA200-1, through -4 had simultaneously acquired a Bglconstitutive expression of the bgl-lacZ fusion and simultaphenotype suggested that the mutations were likely to map neously result in a Bgl-phenotype, are recessive and are within the chromosomal bgl operon. To determine whether complemented by a plasmid expressing the bglS gene. the mutations were linked to the chromosomal bgl operon, Hence, we conclude that these mutations map within the rec+ derivatives of the mutant strains were transduced with bglS gene. This is consistent with our observation that a P1 phages grown on a Bgl+ strain carrying a TnWO insertion derivative of strain MA231 (bglS), which carries the bgl-lacZ in tna linked to the bgl operon. Tetr transductants were fusion, shows constitutive expression of the fusion. The screened for Bgl and Lac phenotypes. About 80% of the Tetr presence of a plasmid expressing the wild-type bglS gene in transductants showed a Bgl+ phenotype. Transduction to this strain also results in inducible expression of the fusion. Bgl+ simultaneously resulted in inducible expression of the These results indicate once again a negative role for the bglS bgl-lacZ fusion, similar to the original strain MA200. In gene product in regulating the expression of the bgl-lacZ addition, X phages carrying the bgl-lacZ fusion were isolated fusion. from the four Lacc mutants and used to relysogenize the Plasmid pMN5, which expresses only the bglS gene, Bgl+ strain MA10. These lysogens showed inducible exprescomplemented the mutations described above, resulting in sion of the bgl-lacZ fusion, similar to the original lysogen an Arb+ phenotype. However, these strains remained Sal-, MA200, indicating that the X prophages carrying the fusion, suggesting that the mutations in strains MA200-1 through -4, present in MA200-1 through -4, are unaltered. Therefore, the are also polar on the bglB gene, similar to the independently mutations leading to constitutive expression of the fusion isolated bglS mutants described earlier (Table 2) . VOL. 169, 1987 The levels of expression of the bgl-laci mutants are higher compared to the induc pression in Bgl+ strains (Table 4 ). This diffe be related to catabolite repression caused b: of glucose 6-phosphate from salicin (the indi strain. Since the bglS mutants show a Bglare unable to utilize the inducer as a substra repression is likely to occur in these strains Mutations leading to constitutive bgl exp original studies on bgl operon expressi( Schaefler described a single mutation that re tutive expression of the bgl operon (7) . indicated that the mutation was located neai With merodiploid analysis, the mutant allel be dominant in trans over the wild type. observation, Prasad and Schaefler propose tion defines a gene which encodes a positive operon expression.
We analyzed the mutation described
Schaefler after transferring it from the origii a bgl plasmid by P1 transduction. The Bg tained, pAR16 and pAR17, were found to be bgl expression, indicating that the mutation successfully transferred to the plasmids. T( tion, a series of hybrid plasmids was constn specific DNA fragments from plasmids pA pSAL6 (Bgl+). a Salicin (7 mM) was used as the inducer.
nal strain SP3 to 4) indicated that the mutation present in strain SP3, which >1+ plasmids obconfers constitutive expression of the bgl operon, lies in the constitutive for 0.2-kb region (between the HindIII and HpaI sites) within in SP3 had been the gene that we have designated bgIC. This is consistent D map the mutawith our observation that the bglC gene encodes a positive ucted by ligating regulator of bgl operon expression. We have designated the kR16 (Bglc) and bglC allele, present in strain SP3, bglC4. nt plasmids (Fig. A second mutation exhibiting constitutive bgl expression, present in strain MA200-33, was obtained by screening the spontaneous Lac+ constitutive mutants of MA200 described~' *~'* in the previous section. Among the 84 Lacc derivatives screened, one (MA200-33) showed constitutive bgl exprespSLL i*od".e sion. Strain MA200-33 showed constitutive bgl expression even when it contained the Bgl+ plasmid pSAL6, indicating pARIG a that the mutation in strain MA200-33 is dominant. When P1 phages grown on a Bgl+ strain carrying a TnJO insertion in pMN33 consttutv tna were used to transduce a recA+ derivative of MA200-33, 80% of the Tetr transductants showed inducible bgl exprespIHNI comtitutlwv sion. This result indicated that the mutation in strain MA200-33 is linked to the chromosomal bgl operon. pIN= coUutive To localize the mutation in strain MA200-33 more precisely, the mutation was transferred to a plasmid by P1 transduction as in the previous case. The resulting plasmid, PM"3sl -pMN33, gave constitutive expression of the bgl operon. The properties of hybrid plasmids, constructed with DNA fragments from pMN33 and pSAL6 (Fig. 4) , indicated that the pMN"E Inducltlmutation in strain MA200-33, which leads to constitutive expression of the bgl operon and the bgl-lacZ fusion, is pMN1ME Coitutive located within the 0.4-kb region upstream of the HpaI restriction site in bglC, i.e., within the bglC structural gene.
pMNS33E inducible
This location of the bglC33 allele indicates that it is distinct from the bglC4 allele. pMNSI lniucible Effect of increased dosage of the bglC and bglS genes on regulation. To understand the mode of action of the regulatory pMN3PI constitutWv genes, the effect ofbglC and bglS in high copy on bgl regulation was studied in strains containing the bgl-lacZ fusion and a single copy of the chromosomal bgl operon ( Table 5 ). The bglC+ plasmid pMN25 had no effect on the expression of the titutive expression bgl-lacZ fusion in the Bgl+ strain MA200, which carries a single rtions; *, pBR322 copy of the bglC and bglS genes on the chromosome. How-(bglC ); , DNA ever, when the bglS+ plasmid pMN5 was present in strain i plasmid pMN33 MA200, the induced level of 3-galactosidase was reduced over
Int containing the twofold. In the presence of the Bgl+ plasmid pSAL6 (bglC+ esent in these two bglS+), the expression of the bgl-lacZ fusion in MA200 was ). The The effect of higher copy numbers of bglC and bglS on the expression of the bgl-lacZ fusion was studied with single copies of the bglC4 and bglC33 alleles on the chromosome. Strains MA46-200 (bglC4) and MA200-33 (bglC33) showed partially constitutive expression of the bgl-lacZ fusion in the presence of the bglC+ plasmid pMN25, indicating the transdominant phenotype of the two bglC alleles. The bglS+ plasmid, pMN5, caused a 75% reduction in the uninduced levels of expression of the bgl-lacZ fusion in strain MA46-200. Thus, the presence of a multicopy plasmid expressing bglS suppressed the constitutive phenotype of the bglC4 allele. However, in contrast to the result obtained with the bglC4 allele, the presence of the bglC33 allele led to constitutive expression of the bgl-lacZ fusion even when plasmid pMN5 (bglS+) was present. Over 75% of the original uninduced level of ,B-galactosidase activity of MA200-33 could be detected in the presence of pMN5. Multiple copies of the bglS gene are unable to effectively suppress the constitutive phenotype of the bglC33 allele. This result suggests that the opposing effects exerted by the bglS and the bglC gene products are not independent. DISCUSSION Organization of the bgl genes. We have shown that the bgl structural genes,which are required for regulated bgl expression, are encoded by the 5.7 kb of DNA located downstream of the bglR site. Since the bglR site has been shown to contain the promoter elements involved in bgl expression (10), our results indicate that the bgl structural genes must be transcribed unidirectionally from bglR rather than bidirectionally as proposed earlier (7). This is also confirmed by the nucleotide sequence analysis of the phoSTU genes immediately upstream of bglR (16) . The phoU open reading frame has been shown to end just upstream of the target region for the insertion sequences in bglR. Therefore, it is not likely that the region upstream of bglR encodes a bgl structural gene. Hence, we conclude that the bgl structural genes are contained within the 5.7-kb region downstream of the bglR site and are transcribed unidirectionally from bglR, constituting an operon.
The results of our analysis of the various Bgl-mutants have indicated that there are at least three structural genes in the operon. We have designated the first structural gene of the operon bglC and the second gene bglS. The bglB gene encoding the enzyme phospho-,-glucosidase B, which mapped downstream of bglS, constitutes the third structural gene of the operon.
Rak and co-workers have determined the nucleotide sequence of the bgl operon, and their results were communicated to us while the manuscript of this paper was in preparation. Their analysis has confirmed the presence of three open reading frames bounded by the same restriction sites defined by our genetic analysis. The conclusions based on the nucleotide sequence analysis of the operon are presented in the accompanying paper by Schnetz et al. (12) .
Role of bglC and bglS in the regulation of the bgl operon. Our studies with a bgl-lacZ transcriptional fusion have shown that the presence of bglC in trans is necessary and sufficient for the expression of the fusion in strains deleted for the chromosomal bgl operon. Since the expression of the fusion does not require a P-glucoside inducer in this case, it is unlikely that the requirement for the bglC gene product is related to an indirect process, such as uptake of ,Bglucosides. We have also shown that loss of bglC function due to mutations results in a Bgl-phenotype, whereas rare mutations in bglC result in constitutive expression of the operon. Hence, we conclude that the bglC gene specifies a positive regulator of bgl operon expression.
The studies with the bgl-lacZ transcriptional fusion have also shown that the bglS gene product is a negative regulator of bgl operon expression. In the presence of bglS and bglC, the expression of the fusion requires a ,B-glucoside inducer. Mutations that inactivate the bglS gene result in constitutive expression of the fusion. The single copy of the chromosomal bglC gene, in this case, stimulates the expression of the bgl-lacZ fusion in the absence of a ,B-glucoside inducer (Table 4) . Therefore, induction of the operon is not likely to occur through the direct activation of the bglC gene product by the inducer. We propose that 3-glucosides induce the bgl operon by relieving the negative effect exerted by the bglS gene product.
The dual regulation of the bgl operon leads to two possible schemes for the operation of the regulatory components. The bglC and bglS gene products could exert their opposing effects either independently or concurrently at the same level of transcriptional regulation. The phenotype of the two bglC mutations (bglC4 and bglC33) that lead to constitutive expression of the bgl operon indicates that a mutation in the bglC gene, in a single step, can overcome the negative effect of the bglS gene product. Therefore, it is more likely that the bglC and bglS gene products act at the same level of regulation, either by competing for a common regulatory site or by directly interacting with each other. The bglC4 and bglC33 alleles are not likely to be mutations that increase the steady-state level of the bglC gene product, since increasing the copy number of the wild-type bglC gene in a cell carrying a single copy of the bglS gene has no appreciable effect on the expression of the bgl-lacZ fusion (Table 5 ). In addition, the presence of the wild-type bglS gene in multiple copies does not seem to have an appreciable effect on the phenotype of the bglC33 allele, as indicated by the measurements of the expression of the bgl-lacZ fusion. The phenotype of the bglC4 allele, however, has been shown to be suppressed under the same conditions. Hence, it is most likely that the bglS gene product exerts its negative effect by directly interfering with the efficient functioning of the bglC gene product. The bglC4 and bglC33 mutations are apparently overcoming the inhibition by bglS, the bglC4 allele being weaker than bglC33 in this respect. We hypothesize that induction of the bgl operon by P-glucosides occurs as a result of a structural alteration of the bglS gene product in the presence of the inducer, which preempts its inhibitory effect on the bglC gene product. Role of bglS in j-glucoside utilization. All of the bglS mutants characterized in this study exhibit a Bgl-phenotype. The presence of the plasmid pMN5, expressing the bglS gene, did not restore the Sal' phenotype in these strains, indicating that the bglS mutants are polar on the bglB gene. The bglS mutants retained their Sal-phenotype even in the presence of plasmid p6J expressing the bglB gene. Since this strain is still incapable of salicin utilization despite the expression of phospho-p-glucosidase B, the bglS gene product must be required in some capacity other than as a negative regulator. The presence of the plasmid pMN5 could restore the Arb+ phenotype in these mutants, indicating that the bglS gene product could facilitate utilization of arbutin. Based on these observations, we propose that the bglS gene product is the bgl-specific component of the phosphotransferase system that is required for the uptake of P-glucosides.
Does the bglC gene product play a direct role in 1B- VOL. 169, 1987 glucoside utilization other than as a positive regulator of bgl operon expression? The observation that plasmid plH, expressing the bglS and bglB genes from a vector promoter, still exhibits an Arb-Sal-phenotype in bglC mutants (Table  2) suggested that the bglC gene product may also be involved in the uptake of P-glucosides. However, plasmid derivatives that carry deletions of the bglC gene, extending toward the bglS gene, conferred an Arb+ Sal' phenotype in the absence of a functional bglC gene. This result suggests that there may be bglC-dependent regulatory sites located on plasmid plH and that deletion of these sites abolishes the requirement of the bglC gene product as a positive regulator. Therefore, it is not likely that the bglC gene product is directly involved in ,-glucoside utilization other than as a positive regulator of bgl operon expression. Thus the bglS and bglB genes alone specify the functions necessary for the utilization of Pglucosides.
The bgl operon is rather unique in specifying a transport protein which also functions as a regulator of gene expression. Studies on the put operon of S. typhimurium, involved in the catabolism of proline, have indicated that the putA gene product is both a negative regulator of put operon expression and a membrane-bound bifunctional oxidasedehydrogenase (4). The glnA gene product of B. subtilis, which constitutes the enzyme glutamine synthetase, has been implicated in the autoregulation of the glnA gene (13) . Hence the presence of regulatory components with multiple functions may be a more common feature among procaryotes than currently understood.
Mode of action of the bglC gene product. Several possible schemes can be postulated for the role of the bglC gene product in transcriptional control. The three basic possibilities are that the bglC gene product functions at the level of (i) transcription initiation, (ii) stabilization of the bgl transcript, or (iii) antitermination at a specific site downstream of the bgl promoter. We have several lines of evidence which indicate that the bglC gene product mediates positive regulation of the bgl operon at the level of antitermination of transcription at a specific rho-independent terminator, downstream of the transcription start site. These results will be reported elsewhere.
